OranoOrano Med Inaugurates ATLab Valenciennes, Europe’s First Industrial Facility Dedicated to the Production of Lead-212-Based Targeted Alpha Therapies Original source on businesswire.comLanguage:EnglishFrançaisThis press release is being prepared.The market announcement is already indexed, but the document has not finished syncing to our storage yet.RefreshOpen original source